[49]
Lane BR, Demirjian S, Derweesh IH, et al. Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate. Eur Urol 2015;68:996–1003.[50]
Karellas ME, O’Brien MF, Jang TL, Bernstein M, Russo P. Partial nephrectomy for selected renal cortical tumours of 7 c m. BJU Int 2010;106:1484–7.
[51]
Peycelon M, Hupertan V, Comperat E, et al. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 c m. J Urol 2009;181:35–41.[52]
Panesar SS, Bhandari M, Darzi A, Athanasiou T. Meta-analysis: a practical decision making tool for surgeons. Int J Surg 2009;7: 291–6.
[53]
Zwahlen M, Renehan A, Egger M. Meta-analysis in medical re- search: potentials and limitations. Urol Oncol 2008;26:320–9.[54]
Volpe A, Amparore D, Mottrie A. Treatment outcomes of partial nephrectomy for T1b tumours. Curr Opin Urol 2013;23:403–10.
[55]
Choi JE, You JH, KimDK, Rha KH, Lee SH. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol 2015;67:891–901.
[56]
Ficarra V, Bhayani S, Porter J, et al. Robot-assisted partial nephrectomy for renal tumors larger than 4 cm: results of a multicenter, international series. World J Urol 2012;30: 665–70.
[57]
Brandao LF, Zargar H, Autorino R, et al. Robot-assisted partial nephrectomy for 7 cm renal masses: a comparative outcome analysis. Urology 2014;84:602–8.[58]
Gupta GN, Boris R, Chung P, Linehan WM, Pinto PA, Bratslavsky G. Robot-assisted laparoscopic partial nephrectomy for tumors great- er than 4 cm and high nephrometry score: feasibility, renal func- tional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol 2013;31:51–6.[59]
Masson-Lecomte A, Yates DR, Bensalah K, et al. Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study. Eur J Surg Oncol 2013;39:799–803.[60]
Shuch B, Amin A, Armstrong AJ, et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportu- nities from biologic complexity. Eur Urol 2015;67:85–97.E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 6 0 6 – 6 1 7
617




